Cimetidine in colorectal cancer--are the effects immunological or adhesion-mediated?
- PMID: 11870499
- PMCID: PMC2375193
- DOI: 10.1038/sj.bjc.6600097
Cimetidine in colorectal cancer--are the effects immunological or adhesion-mediated?
Abstract
British Journal of Cancer (2002) 86, 159–160. DOI:
© 2002
Comment on
-
Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells.Br J Cancer. 2002 Jan 21;86(2):161-7. doi: 10.1038/sj.bjc.6600048. Br J Cancer. 2002. PMID: 11870500 Free PMC article. Clinical Trial.
References
-
- AdamsWJMorrisDL1994Short-course cimetidine and survival with colorectal cancer Lancet 34417681769 - PubMed
-
- AdamsWJMorrisDL1997Pilot study – cimetidine enhances lymphocyte infiltration of human colorectal carcinoma: results of a small randomized control trial Cancer 801521 - PubMed
-
- AdamsWJMorrisDLRossWBLubowskiDZKingDWPetersL1994bCimetidine preserves non-specific immune function after colonic resection for cancer Aust NZ J Surg 64847852 - PubMed
-
- ArmitageJOSidnerRD1979Antitumour effect of cimetidine Lancet 1882883 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
